The North America contract research organization (CRO) services market size attained a value of USD 26.27 Billion in 2024 driven by increasing research and development expenditures in the region. The market is expected to grow further at a CAGR of 7.70% during the forecast period of 2025-2034. It is likely to reach a value of USD 55.16 Billion by 2034.
Base Year
Historical Year
Forecast Year
The rising adoption of advanced technologies such as artificial intelligence (AI), machine learning, and big data analytics for effective research and development outcomes by the leading CROs is driving growth and innovation in the market.
The United States represents the largest share of the market due to the high concentration of leading pharmaceutical and biotechnology companies. The Canadian market for contract research organization (CRO) services benefits from robust government support and growth in clinical trials.
The market share is impacted by the increasing development and production of biopharmaceuticals, the rapid growth of the biotech sector, and rising market consolidation through mergers and acquisitions.
Value in USD Billion
2025-2034
North America Contract Research Organization (CRO) Services Market Outlook
*this image is indicative*
Contract research organizations (CROs) offer research-based services to government agencies in the pharmaceutical, biotechnology, and related sectors. They can be either major, full-scale organisations, with an international presence or small, specialised organisations with a narrow focus that provide drug and device research and development (R&D) services, such as drug discovery, preclinical research, and clinical research, among others.
The North America contract research organization (CRO) services market is positively impacted by the rising investment in research and development (R&D) by pharmaceutical and biotechnology companies to discover and develop new therapies. Moreover, CROs are increasingly leveraging advanced technologies such as artificial intelligence (AI), machine learning, and big data analytics, in conducting clinical trials, which is stimulating the growth of the global contract research organization (CRO) services market . Other factors influencing the expansion of contract research organizations (CROs) include increased disease monitoring and screening, the requirement for routine diagnostics in healthcare settings, the spread of chronic diseases like diabetes, and the rise in new strains of infectious diseases. These factors are supported by government public health screening policies, the massive increase in patient specimens tested in labs, and the resulting demand for clinical lab testing services.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growth in Strategic Partnerships to Meet Rising Demand
In September 2023 , Parexel International (an American clinical research organization and biopharmaceutical services company) and IT services company Partex signed a deal to combine artificial intelligence-powered solutions with clinical research expertise. The partnership aims to expedite drug discovery and development for biopharmaceutical clients globally and de-risk their assets by predicting the investigational candidates that offer the strongest probability of clinical success. Through this collaborative initiative, Partex intends to enhance customer clinical trial execution by leveraging the Partex-validated AI platform. Such strategic partnerships that prioritize the usage of advanced tools to accelerate the development of safe and effective therapies are poised to fuel market growth in the region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current scenario in North America. Some of the notable trends are as follows:
North America Contract Research Organization (CRO) Services Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Service
Market Breakup by Therapeutic Area
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on End Users is Anticipated to Witness Substantial Growth
On the basis of end users, the market can be segmented into pharmaceutical and biopharmaceutical companies, medical device companies, and research and academic institutes, among others. Pharmaceutical and biopharmaceutical companies are predicted to lead the market in terms of revenue throughout the forecast period. The demand for the segment is anticipated to increase as a result of the growing trend of pharmaceutical and biotechnology companies outsourcing end-to-end services, particularly among small and mid-size businesses lacking significant expertise in the preclinical stage of drug development. The prevalence of chronic illnesses like cancer, diabetes, heart disease, and neurological and infectious diseases is also increasing, and pharmaceutical and biopharmaceutical companies are investing more money in creating new treatments, which is anticipated to fuel market expansion.
The market segmentation by region includes the United States and Canada. The United States represents the largest share of the market due to the strong presence of leading pharmaceutical and biotechnology companies which drive the demand for CRO services. Further, substantial investments in research and development (R&D) and growth in clinical trials in the region stimulate market growth. Canada is another major market in North America which benefits from robust government support and a favorable environment for clinical research.
The key features of the market report comprise funding and investment analysis and strategic initiatives. The major companies in the market are as follows:
IQVIA Holdings Inc., established in 1982, is a prominent global provider of clinical research services, advanced analytics, and technological solutions to the life sciences industry. Through its analytics, disruptive technologies, in-depth topic understanding, and big data resources, IQVIA forges intelligent linkages across all facets of healthcare. IQVIA is headquartered in North Carolina in the United States.
Thermo Fisher Scientific Inc., headquartered in the United States, is a provider of scientific equipment, reagents and consumables, and software services. The 1956-founded business provides goods and services that benefit clients all over the world in hospitals and laboratories, on assembly lines, and in the field. It is a driving force in the research, healthcare, industrial, and application markets.
Medpace Holdings Inc., one of the leading key players contributing to the North America contract research organization (CRO) services market growth was established in 1992. It is a full-service, globally active clinical contract research organization (CRO) with a scientifically-driven approach and offers these services to the biotechnology, pharmaceutical, and medical device industries. Through its high-science and disciplined operating approach, which draws on local regulatory and in-depth therapeutic expertise in all important areas, including endocrinology, oncology, cardiology, central nervous system, metabolic disease, and anti-viral and anti-infective therapies, Medpace seeks to accelerate the global development of safe and effective medical therapeutics.
This American provider of biopharmaceutical services has a prominent market presence and is engaged in conducting clinical trials for its pharmaceutical clients in order to accelerate the drug approval process. Parexel International Corporation employs advanced technologies such as artificial intelligence (AI) and big data analytics to improve the efficiency of clinical trials. It often collaborates with pharmaceutical and biotechnology companies to offer end-to-end clinical trial management services.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Laboratory Corporation of America Holdings, Clinipace, ICON plc, Medpace, Inc., AcceGen Biotechnology, Admescope Ltd., Stelis Biopharma Pvt. Ltd, Almac Group Limited, and Andelyn Biosciences Inc.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Service |
|
| Breakup by Therapeutic Area |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share